Up next

Autoplay

HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches

0 Views • 07/03/23
Share
Embed
administrator
administrator
Subscribers
0

Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay